Condition: Clinical Stage IA Cutaneous Melanoma AJCC v8 · Clinical Stage IB Cutaneous Melanoma AJCC v8 · Sponsor: OHSU Knight Cancer Institute
This clinical trial compares the effect of a narrow surgical excision (removal) to a wide excision for the treatment of adults with invasive cutaneous melanoma. Currently the standard of care is to take wide margins (boarder of healthy tissue surrounding the melanoma) when removing melanoma. Narrow margin excision removes a smaller amount of healthy tissue when surgically removing the melanoma. Narrow margin excision may be effective in removing the melanoma while also reducing surgical complications and improving quality of life for adults with invasive cutaneous melanoma.
This description comes directly from the study's public registry record.
Paige Smith · 503-418-4268 · smitpaig@ohsu.edu
Always discuss trial participation with your own doctor first.
| University of California, Davis | Davis, California, United States | Not Yet Recruiting |
| University of Kentucky/Markey Cancer Center | Lexington, Kentucky, United States | Not Yet Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Not Yet Recruiting |
| University Hospitals Cleveland Medical Center | Cleveland, Ohio, United States | Not Yet Recruiting |
| OHSU Knight Cancer Institute | Portland, Oregon, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06673095